A Multi-institutional Analysis of the Combined Effect of Micropapillary Component and Consolidation-to-Tumor Ratio >0.5 on the Prognosis of Pathological, Stage IA3, Lung Adenocarcinoma.

INTRODUCTION: The study investigated the synergistic effect of the micropapillary (MIP) component and consolidation-to-tumor ratio (CTR) on the recurrence and survival of patients with pathologic stage IA3 lung adenocarcinoma. METHODS: We enrolled 419 patients confirmed pathological stage IA3 adenocarcinoma from four institutions. Kaplan-Meier analysis was performed to examine the value of the MIP component and CTR on relapse-free survival (RFS) and overall survival (OS). The cumulative recurrence between different stages was analyzed by using cumulative event curves. RESULTS: RFS (P < 0.0001) and OS (P = 0.008) in the presence of the MIP group were significantly lower than those in the absence of the MIP group, and CTR > 5 only reduced RFS (P = 0.0004), but not OS (P = 0.063), in the patients. In addition, the prognosis of patients with both the MIP component and CTR > 5 was worse than that of those without the MIP component or CTR ≤ 5. Therefore, we established new subtypes of the stage IA3: IA3a, IA3b, and IA3c. RFS and OS for IA3c staging were significantly lower than those for IA3a and IA3b. For IA3c, the cumulative incidence of local recurrence (P < 0.001) and that of distant metastasis (P = 0.004) were significantly higher than those for IA3a and IA3b. CONCLUSIONS: The MIP component combined with CTR > 0.5 can effectively predict the prognosis of patients with pathological stage IA3 lung adenocarcinoma and may offer more detailed recurrence and survival information according to the established subtype stage of IA3.

Diverse manganese(II) coordination polymers derived from achiral/chiral imidazolium-carboxylate zwitterions and azide: structure and magnetic properties.

Five Mn(II) coordination polymers containing azide and carboxylate as simultaneous bridges have been derived from different imidazolium-carboxylate zwitterionic ligands: 1-methyl-3-(carboxylatomethyl)imidazolium (L(1)), 1,3-bis(carboxylatomethyl)imidazolium (L(2)), (S,S)-, (R,R)-, and (R,S)-1,3-bis(1-carboxylatoethyl)imidazolium (S,S-L(3), R,R-L(3) and R,S-L(3)). The compounds are formulated as [Mn(L(1))(N3)2] (1), [Mn(L(2))(N3)] (2), [Mn(R,R-L(3))(N3)]·0.5CH3OH (3-R), [Mn(S,S-L(3))(N3)]·0.5CH3OH (3-S), [Mn(R,S-L(3))(N3)] (4). In compound 1, the neutral monocarboxylate zwitterion ligand (L(1)) leads to uniform chains with bis(azide)(carboxylate) bridges. For compounds 2-4, the anionic dicarboxylate zwitterions L(2) and L(3) lead to (azide)bis(carboxylate) bridges, but the overall coordination networks are different. In 2 and 3-S (or 3-R), chains with the (azide)bis(carboxylate) bridges are connected by L(2) and S,S-L(3) (or R,R-L(3)), respectively, to give achiral and chiral 2D coordination networks with different connecting topologies. In compounds 4, which is derived from the mesomeric ligand R,S-L(3), linear trinuclear units with the (azide)bis(carboxylate) bridges are linked by µ-1,3 azides to give 2D layers, and the layers are pillared into a 3D framework by the 1,3-dimethyleneimidazolium tethers. Magnetic analyses suggested that compounds 1-3 behave as 1D antiferromagnetic systems, while 4 shows canted antiferromagnetism with weak ferromagnetic ordering below T(C) = 12.4 K.

[Construction of a recombinant lentiviral vector of p38 MAPK and establishment of a human prostatic carcinoma cell line stably expressing p38 MAPK].

OBJECTIVE: To construct a recombinant lentiviral vector for p38 MAPK and establish a human prostatic carcinoma cell line that stably expresses p38 MAPK. METHODS: EGFP/p38 fusion gene was subcloned into the lentiviral vector pTYF- EF1α-IRES-EGFP. The recombinant lentiviral vector pTYF-EF1α-EGFP/p38 was indentified by restriction enzyme digestion, and packaged in HEK 293T cells using lipofectamintm2000 with the packaging plasmid psPAX2 and envelope plasmid pMD2.G. The viral titer was tested according to the expression level of GFP. The resulting recombinant lentiviral vector was transduced into human prostatic carcinoma DU145 cells, and stably transduced cells were selected by limiting dilution analysis. The intracellular expression level of total p38 was detected by Western blotting and the cell growth curve was drawn. RESULTS: DNA restriction enzyme digestion demonstrated that the recombinant lentiviral vector of the fusion gene EGFP/p38 (pTYF-EF1α-EGFP/p38) was constructed successfully. The recombinant lentiviral vector was packaged in 293T with a viral titer of 4.7×10(6) TU/ml. A stable cell line, EGFP/p38-DU145, was established, which stably expressed exogenous EGFP/p38 MAPK fusion protein as detected by Western blotting and showed a lowered growth rate compared to the control cells. CONCLUSION: We have successfully constructed a recombinant lentiviral vector of the fusion gene EGFP/p38 and established a stable cell line EGFP/p38-DU145. Overexpression of p38 has a significant inhibitory effect on the proliferation of DU145 cells in vitro.